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Background: Acute kidney injury requiring renal replacement therapy (RRT) in the 
intensive care unit portends a poor prognosis. The decisions regarding dialysis catheter 
placement is based mainly on physician discretion with little evidence to support the 
choice of dialysis catheter location.                                                                                                             
Methods: The Veterans Affairs/National Institutes of Health Acute Renal Failure Trial 
Network Study was a multicenter, prospective, randomized trial of intensive vs. less 
intensive RRT in critically ill patients with AKI. We assessed the association of dialysis 
catheter location with dialysis catheter-related outcomes including catheter-related 
complications, mortality, dialysis dependence, and dialysis dose delivered.
results: Of the 1,124 patients enrolled in the ATN study, catheter data were available 
in 1,016 (90.39%) patients. A total of 91 (8.96%) subclavian, 387 (38.09%) internal 
jugular, and 538 (52.95%) femoral dialysis catheters were inserted. The femoral group 
was younger (58.39  ±  16.27), had greater bleeding tendency [lower platelet count 
(96.00 ± 109.35) with higher INR (2.01 ± 2.19)], and had a higher baseline sequential 
organ failure assessment score on admission (14.59 ±  3.61) compared to the other 
two groups. Dialysis catheter-related complications were low in this study with no sig-
nificant difference in the rates of complications among all catheter locations. Mortality 
and dialysis dependence was lowest in the subclavian group, while the dose of dialysis 
delivered (Kt/V) remained lowest in the femoral group, after propensity score and center 
adjustments.
conclusion: Patient characteristics influence the choice of dialysis catheter location 
with a tendency to place femoral catheters in younger, sicker, and more coagulopathic 
patients. There were no statistically significant differences in complication rates among 
the three catheter locations, although femoral catheters may be associated with a lower 
delivered dose of dialysis during intermittent hemodialysis.
clinical Trial registration: www.ClinicalTrials.gov, identifier NCT00076219.
Keywords: acute kidney injury, complications, dialysis catheter, dialysis dose, mortality
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inTrODUcTiOn
Establishing temporary vascular access is essential for patients 
with acute kidney injury requiring renal replacement therapy 
(RRT) (1). The placement of a central venous dialysis catheter, 
however, may negatively affect the morbidity and mortal-
ity of patients with AKI, especially in the intensive care unit 
(ICU) setting. Mechanical complications such as inadvertent 
arterial puncture, which can result in excessive bleeding or 
thrombotic complications, pneumothorax, hemothorax, air 
embolism as well as cardiac arrhythmia are infrequent but may 
be potentially fatal especially in the critically ill patients (2). 
Furthermore, the presence of a catheter increases the risk of 
catheter-related bloodstream infection and catheter malfunc-
tion (3). The frequencies of these complications depend on 
catheter factors including catheter location (internal jugular 
vs. femoral vs. subclavian), duration of catheter placement; 
patient factors including body habitus, comorbidities, patient 
coagulopathies, and the severity of patient illness as well as 
operator experience. Placement of subclavian dialysis catheters 
has been strongly discouraged due to the high incidence of 
subclavian vein stenosis post catheter insertion (4, 5). Femoral 
catheters, on the other hand, have been associated with deep 
venous thrombosis (6, 7).
Several guidelines exist with recommendations for dialysis 
catheter placements in the setting of AKI including location, 
duration, and types of catheter placement although none are sup-
ported by strong evidence and generally suggest using internal 
jugular site for acute hemodialysis mainly to reduce infection 
risk and for patient comfort (8–10). The most recent CDC guide-
line recommends that femoral central line placement should 
be avoided (10). The 2006 KDOQI guidelines suggest internal 
jugular catheters should not be used for more than a week, while 
femoral catheters should be left in place for no more than 5 days 
and only in bed-bound patients due to the high risk of dislodge-
ment (9). In the KDIGO guideline for AKI published in 2012, it 
was suggested that the first choice for dialysis catheter placement 
should be the right internal jugular, followed by femoral, and 
then left internal jugular (8). Historical data suggest that femoral 
catheters have a higher risk of infection due to the proximity to 
the groin (2, 11). This assumption, however, has been disproven 
in the Cathedia study, which was a large randomized, controlled 
trial comparing the risk of nosocomial events in femoral vs. 
jugular venous catheterization in AKI patients (12). The study 
concluded that the risk of nosocomial infection was comparable 
between jugular and femoral catheters except for patients with 
high BMI, whereby jugular placement was associated with a lower 
risk of infection. The Cathedia study remains the largest and only 
randomized controlled trial to date looking at the effect of dialysis 
catheter location on infection; however, the study focused mainly 
on catheter-related infections and did not specifically address the 
impact of location of catheter on other outcomes of the catheter 
such as dialysis adequacy, complication rates such as pneumotho-
rax, hemothorax, and bleeding as well as mortality and dialysis 
dependence.
To better understand the relationship of catheter site to these key 
outcomes, we used the Veterans Affair/National Institute of Health 
Acute Renal Failure Trial Network study, which was a multicenter, 
prospective, randomized parallel-group trial assessing the effect 
of intensity of hemodialysis on mortality in critically ill patients 
with AKI (13). We took advantage of the ATN study to test whether 
complication rates, dialysis dose delivered, mortality, and dialysis 
dependence were related to three different catheter locations in 
critically ill patients requiring RRT.
MaTerials anD MeThODs
study Participants
Patients enrolled in the ATN study were critically ill adults 
(18  years or older) who had AKI clinically consistent with 
acute tubular necrosis and failure of one or more non-renal 
organ [defined as a non-renal sequential organ failure assess-
ment (SOFA) score of ≥2]. Inclusion and exclusion criteria 
are available in the original VA/NIH Acute Renal Failure Trial 
manuscript (13). The Institutional Review Board (IRB) of the 
University of New Mexico approved this secondary analysis 
of the ATN Trial. All study participants or their health-care 
surrogates provided informed consent to participate in ATN, 
and the ethics committees/IRBs of participating centers had 
reviewed and approved the consent form during protocol 
review. These documents and the ATN protocols can be down-
loaded from the NIDDK repository. Individual ATN partici-
pants were not consented for this secondary analysis, because 
the data as distributed by the NIDDK have been de-identified. 
Furthermore the data use agreement between the investigators 
of this paper and NIDDK prohibits us from making any contact 
to identify individuals, families, or communities. The IRB of 
the University of New Mexico waived the requirement for an 
informed consent for this secondary analysis after review-
ing the original consent form that ATN participants signed 
upon their enrollment, the data use agreement between the 
investigators and NIDDK, and the associated research protocol 
submitted to the NIDDK.
catheter Placement
In this study, the site of dialysis catheter insertion and 
indication for removal of catheter was based on physician 
discretion. Data captured during catheter insertion process 
included date and time of catheter insertion, number of 
catheters inserted per patient, temporary or tunneled catheter 
placement, location of catheter, and insertion complications 
including early and late complications (late being defined as 
complications occurring at >24 h from catheter insertion to 
3 days after catheter removal). Date and time as well as reason 
for catheter removal were also captured. Only first catheter 
placements were included in the primary analysis. Recurrent 
catheter insertion and complications were not assessed in this 
study.
complications
Complications collected related to catheter placement included 
infection, cardiac arrhythmia, pneumothorax, hemothorax, arte-
rial puncture, local venous thrombosis, and air embolism.
TaBle 1 | Baseline characteristics.
catheter location P 
values
subclavian 
(n = 92)
internal jugular 
(n = 387)
Femoral 
(n = 538)
Baseline characteristic
Age, year 59.82 ± 14.24 61.62 ± 14.22 58.39 ± 16.27 <0.01
Male 65 (70.65) 282 (72.68) 368 (68.40) 0.37
BMI 26.86 ± 6.13 28.96 ± 6.34 27.66 ± 5.76 <0.01
comorbidities
Liver disease 9 (9.78) 45 (11.60) 64 (11.90) 0.52
Diabetes 35 (38.04) 118 (30.41) 146 (27.14) 0.08
Hypertension 5 (5.43) 13 (3.35) 16 (2.99) 0.32
PVD 24 (26.09) 85 (21.91) 62 (11.52) <0.01
CVD 1 (1.09) 2 (0.52) 3 (0.56) 0.72
CHF 23 (25.00) 104 (26.80) 118 (21.93) 0.23
CVA 7 (7.61) 38 (9.79) 49 (9.11) 0.8
laboratory values
WBC  
(× 102 cells/mm3)
14.85 ± 9.53 12.50 ± 10.01 13.40 ± 11.89 0.14
Platelets  
(× 103 cells/mm3)
101.00 ± 146.77 114.50 ± 111.49 96.00 ± 109.35 <0.01
INR 1.61 ± 1.04 1.64 ± 0.78 2.01 ± 2.19 <0.01
BUN (mg/dL) 66.57 ± 32.84 70.41 ± 33.81 61.46 ± 33.32 <0.01
Creatinine  
(mg/dL)
3.92 ± 1.53 4.26 ± 1.77 3.98 ± 2.51 0.02
Albumin (g/dL) 2.34 ± 0.69 2.48 ± 0.87 2.36 ± 0.73 0.08
clinical parameters
Sepsis 54 (64.29) 179 (48.38) 289 (57.23) <0.01
MAP (mmHg) 74.17 ± 14.26 73.89 ± 13.62 73.86 ± 15.39 0.98
Edema 23 (71.88) 88 (67.18) 63 (57.27) 0.3
Intubation 75 (81.52) 293 (75.52) 455 (84.57) <0.01
SOFA 13.26 ± 3.75 13.07 ± 3.79 14.59 ± 3.61 <0.01
MAP, mean arterial pressure; PVD, peripheral vascular disease; CVD, cardiovascular 
disease; CHF, congestive heart failure; CVA, cerebrovascular accidents; SOFA, 
sequential organ failure assessment.
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hemodialysis and Patient Outcomes
We looked at the associations among the three different catheter 
locations on catheter function, duration of catheter placement, 
and dialysis dose delivered. We attempted to address the issue 
of catheter malfunction by looking at a combination of factors, 
acknowledging that no one factor can be used to define cateter 
malfunction, including the blood flow rate achieved during 
dialysis, the number of filters changed in a 24-h period, and the 
incidence of clotting events that required filter change. In addition, 
we assessed the association between the choice of catheter loca-
tion on patient outcomes including 60-day mortality and dialysis 
dependence.
statistics
Primary comparisons of baseline patient characteristics among 
the three groups were defined by the location of the initial cath-
eter placement and were performed using analyses of variance for 
continuous variables and chi-square tests for categorical variables. 
To account for renal recovery as a potential competing risk factor 
for mortality, we looked at the combined outcome of real recovery 
and mortality. Comparisons of the combined renal recovery and 
60-day mortality outcomes among the catheter placement groups 
were made using multinomial regression models. Analyses for 
Kt/V were accomplished using repeated measures analysis of 
variance. Because catheter placement was not randomized, and 
was influenced by the clinicians’ perceptions of their patients, 
we repeated the analyses while attempting to correct for differ-
ences among groups via the application of propensity weights. 
Propensity weights were estimated by the twang (version 1.4-9.3) 
(14) package in R (version 3.2.3) using all baseline covariates as 
shown in Table 1. As there were individuals with missing data, we 
performed a multiple imputation approach for missing values of 
the patient characteristics using the “chained equations” approach 
(15). This method fits a regression model for each variable with 
missing data, conditional on other variables, and makes a pre-
diction for each missing value from the fitted regression model. 
Ten data sets with complete data were generated, and propensity 
weights appropriate for estimating the average treatment effect 
were obtained from each data set. The geometric mean of the 
estimated propensity weights was obtained for each participant 
across the 10 imputed data sets. Analyses were repeated to compare 
the outcomes of interest among the groups with different initial 
catheter placement locations while weighting the individuals by 
their estimated propensity scores. Subsequent analyses adjusted 
for the different study sites were also performed using generalized 
estimating equations approaches. All analyses with the exception 
of the propensity weights were computed using SAS version 9.4 
(Cary, NC, USA) and R (version 3.2.3).
resUlTs
A total of 1,124 patients were enrolled in the ATN study between 
November 2003 and July 2007. Data on dialysis catheter place-
ment was available in 1,016 (90.39%) of the study patients. A total 
of 91 (8.96%) subclavian catheters, 387 (38.09%) internal jugular 
catheters, and 538 (52.95%) femoral catheters were placed.
Baseline characteristics
Table 1 demonstrates the baseline characteristics of the patients 
by catheter site. The femoral group was younger, more coagu-
lopathic with a higher INR, and sicker with a higher baseline 
SOFA score compared to the other two groups. There were 
comparable number of patients with documented edema and 
congestive heart failure. The internal jugular group had the 
highest BMI among the three groups. Comorbidities including 
diabetes, hypertension, cardiovascular disease, cerebrovascular 
accidents, and liver disease were comparable among the three 
groups with the exception of peripheral vascular disease (PVD) 
with the femoral group having less PVD compared to the other 
groups.
There were more patients who were intubated in the femoral 
group compared to the subclavian and internal jugular group. 
The use of inotropic agents was, however, comparable among the 
three groups. The femoral group was started on RRT at a lower 
BUN compared to the other two groups.
Outcomes
Catheter Complications
The reported rates of catheter-related complications were 
uniformly low in this study. There were no reported cases of 
TaBle 4 | Dialysis dose and catheter malfunction.
subclavian internal jugular Femoral P values
continuous renal replacement therapy
Blood flow (mL/min) 135.00 ± 31.72 150.00 ± 32.07 150.00 ± 34.01 <0.01
Dialyzate flow (mL/h) 1,250.00 ± 499.58 1,050.00 ± 466.33 1,150.00 ± 482.66 0.04
Duration (h) 19.00 ± 6.92 20.00 ± 7.09 20.00 ± 6.91 <0.01
Effluent volume (L/day) 34.00 ± 22.32 39.00 ± 23.38 39.30 ± 21.44 <0.01
CVVHDF clota 209 (51.48) 730 (38.34) 994 (40.59) <0.01
Anticoagulation 538 (51.83) 2,333 (50.17) 3,090 (54.17) <0.01
intermittent hemodialysis
Blood flow (mL/min) 400.00 ± 70.08 350.00 ± 62.82 350.00 ± 75.74 <0.01
DFR (mL/min) 800.00 ± 127.36 800.00 ± 153.48 800.00 ± 183.08 <0.01
Duration (h) 4.00 ± 0.94 4.00 ± 1.66 4.00 ± 2.64 <0.01
Hemo clotb 47 (14.83) 169 (9.30) 263 (13.75) <0.01
Anticoagulation 463 (44.61) 2,229 (47.94) 2,504 (43.90) <0.01
Kt/V 1.27 ± 0.38 1.32 ± 0.37 1.24 ± 0.34 <0.01
Duration of catheter (days) 7.90 ± 7.62 8.30 ± 5.75 6.42 ± 4.74 <0.01
Propensity score adjustment
Kt/V 1.21 ± 0.04 1.29 ± 0.04 1.20 ± 0.04 <0.01
Blood flow, dialyzate flow, duration of dialysis, and effluent volume are expressed as median ± SD.
aCVVHDF clot: CVVHDF clotting requiring hemodiafilter replacement.
bHemo clot: clotting requiring hemodialyzer replacement.
TaBle 3 | catheter-related infections.
subclavian internal 
jugular
Femoral P values
Unadjusted (incidence per 1,000 catheter days)
Bacteremia (95% CI) 6.7 (3.8–11.9) 4.6 (3.2–6.5) 2.6 (1.8–3.7) 0.009
Catheter-related 
infections (95% CI)
2.2 (0.8–6.0) 2.0 (1.2–3.4) 0.9 (0.5–1.7) 0.1
Propensity score adjustment (incidence per 1,000 catheter days)
Bacteremia (95% CI) 5.8 (3.6–9.3) 4.8 (3.4–6.7) 5.7 (4.0–8.2) 0.72
Catheter-related 
infections (95% CI)
3.1 (1.6–5.9) 2.2 (1.3–3.6) 2.4 (1.4–4.2) 0.72
TaBle 2 | catheter-related complications.
subclavian internal 
jugular
Femoral P values
Arterial puncture 0 (0) 1 (0.26) 3 (0.56) 0.63
Bleeding 0 (0) 9 (0.19) 5 (0.09) 0.15
Excessive bleed 1 (1.09) 3 (0.77) 4 (0.74) 0.94
Late excessive bleed 2 (2.17) 3 (0.77) 2 (0.37) 0.15
Cardiac arrhythmia 0 (0) 5 (1.41) 2 (0.40) 0.17
Local venous thrombosis 0 (0) 0 (0) 1 (0.19) 0.64
Late local thrombosis 0 (0) 0 (0) 3 (0.56) 0.26
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hemothorax and air embolism. Cardiac arrhythmia was most 
commonly reported in the internal jugular group although this 
difference did not reach statistical significance. Other complica-
tions including inadvertent arterial puncture, bleeding, excessive 
bleeding, and venous thrombosis were comparable among the 
three groups (Table 2).
In this study, 19.57% of all enrolled patients had blood cultures 
obtained, and 26.58% of the catheter tips were sent for culture 
upon catheter removal. The incidence of bacteremia as well as 
catheter-related infections was comparable among all catheter 
groups (Table 3). The most commonly cultured organism was 
Staphylococcus epidermidis followed by methicillin-resistant 
Staphylococcus aureus and vancomycin-resistant Enterococcus.
Catheter Malfunction and Dialysis Dose
We assessed the functionality of the dialysis catheter by assess-
ing a combination of factors including the blood flow achieved 
during dialysis, the duration of placement for each catheter, the 
dose of dialysis delivered, and the frequency at which the filters 
clotted or were changed in each catheter group. The femoral 
group had the shortest duration of catheter placement and the 
lowest Kt/V compared to the other groups. The subclavian group 
reported a higher rate of clotting compared to the femoral and 
internal jugular group both during continuous renal replace-
ment therapy (CRRT) and intermittent hemodialysis (IHD) 
although the number of filters changed within a 24-h period 
was not clinically different. Interestingly, the blood flow rate 
achieved was the lowest in the subclavian group during CRRT, 
whereas it was the highest during IHD. The dose of dialysis 
delivered during IHD was lowest in the femoral group, and this 
difference persisted even after propensity score adjustments 
(Table 4).
Patient Outcomes
The 60-day mortality rate in this study population was 45.64%. As 
noted in Figure 1, there was a significant difference in mortality 
among the three catheter locations. To address the question of 
whether this difference in mortality seen was due to the unequal 
distribution of the patient population and to account for renal 
recovery as a potential competing risk factor, we analyzed the 
effect of catheter location on mortality and dialysis dependence 
using a multinomial regression model.
Patient mortality remained lower in the subclavian group (OR 
0.55; 95% CI 0.4–0.81) and the internal jugular group (OR 0.75; 
95% CI 0.57–0.98) when compared to the femoral group, while 
dialysis dependence was noted to be lower in the subclavian group 
FigUre 1 | Unadjusted survival curve by catheter location.
5
Ng et al. Acute Kidney Injury Vascular Access
Frontiers in Medicine | www.frontiersin.org April 2017 | Volume 4 | Article 40
compared to the femoral group (OR 0.58; 95% CI 0.41–0.83) with 
no significant difference between the internal jugular group and 
the femoral group (OR 1.01; 95% CI 0.75–1.35) after propensity 
score and center adjustment (Figure 2).
DiscUssiOn
Key Findings
Our study demonstrated that complications related to catheter 
placement were low and fairly comparable across the three cath-
eter sites, while lower delivered dose of dialysis during IHD was 
seen in the femoral group compared to the SC and IJ group. In 
this study, we also showed that patient characteristics influence 
the choice of dialysis catheter location with a tendency to place 
femoral catheters in younger, sicker, and more coagulopathic 
patients, which may have influenced the rates of mortality and 
renal recovery.
Sixty-day mortality and dialysis dependence was noted to 
be lowest in the subclavian group compared to the femoral and 
internal jugular groups even after propensity score and center 
adjustment. The distribution of propensity scores in the sub-
clavian group was considerably different from the distributions 
of the propensity scores in the internal jugular and femoral 
groups. This suggests that patients who received a subclavian 
catheter were markedly different at baseline compared to the 
other two catheter groups, and the current findings on lower 
mortality and dialysis dependence in this group may reflect the 
difference in the patient population who received a subclavian 
catheter. We have attempted to address this shortcoming by 
using propensity weights although there may be factors that we 
could not adequately account for. The choice of dialysis catheter 
location will likely continue to depend on physician experience 
and patient characteristics, for example, patients with high BMI 
receiving internal jugular catheters. Femoral catheters often are, 
and likely will remain, the site of choice in the cases of emergen-
cies (1, 16).
relationship to Previous studies
In this study, however, we did demonstrate that the difference 
in catheter location impacts catheter function and dialysis dose 
delivered. We acknowledge that there is no single parameter that 
determines catheter functionality, and certain parameters may be 
influenced by physician decisions, hence we looked at a combina-
tion of factors including catheter blood flow rates, duration of 
catheter usage, dialyzer clotting resulting in filter change as well 
as dialysis dose delivered (17, 18). In comparison to the Cathedia 
study, we noted a higher incidence of catheter malfunction in 
the femoral group compared to the other groups as shown by 
the shorter catheter duration and lower delivered Kt/V (19). One 
potential explanation for this difference may be the exclusion of 
patients who could not be randomized due to medical reasons in 
the Cathedia study (e.g., coagulopathic patients in whom jugular 
catheter insertion may result in a higher risk for bleeding) hence 
eliminating patients who could be at higher risk for catheter 
malfunction in that trial.
Two other randomized studies, performed in critically ill 
patients in the ICU, both found a higher rate of venous thrombo-
sis in the femoral group (1, 20). However, these studies involved 
central venous catheter placement and not dialysis catheter 
placement, hence the issue of catheter malfunction and dialysis 
dose was not assessed. Studies looking specifically at dialysis 
catheter placements have also found that femoral catheters to 
FigUre 2 | catheter location and outcomes.
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be associated with high risk for venous thrombosis (11, 21, 22), 
more recirculation (23, 24), and catheter malfunction. However, 
like our study, these studies were not randomized controlled tri-
als. To our knowledge, we are the first to document that femoral 
catheters may be associated with a lower delivered dose of dialysis 
during IHD (Kt/V). Dialysis dose in patients with acute kidney 
injury requiring CRRT has been established based on the VA/
NIH ATN study (13) and the RENAL study (25). However, the 
prescribed Kt/V for AKI patients on IHD has not been clearly 
determined. There is evidence to suggest that higher dose of 
dialysis in AKI patient on IHD may enhance survival (26–29), 
although this has not been proven in randomized controlled tri-
als. The implication of our finding is intriguing and may suggest 
that when using femoral catheters for dialysis, a higher dose of 
dialysis may need to be prescribed to overcome the lower dose of 
dialysis delivered during IHD with this catheter location.
strengths and limitations of the study
The VA/NIH ATN study was a large, multicentered study with 
patients recruited from multiple sites throughout the US. The 
heterogeneity of the population allows for greater applicability 
of this study to the general ICU population. The prospective 
collection of a significant amount of outcomes data and the clear 
definition of each outcome collected from this study also allowed 
us to study the various complications and outcomes associated 
with the different dialysis catheter locations and to adjust for 
numerous factors that could potentially affect the outcomes.
The interpretation of these findings should be performed in 
light of several important limitations. First, this is a secondary 
data analysis of a clinical trial, and we note the lack of rand-
omization of our study for catheter placement. We addressed 
this shortcoming by using statistical approaches to attenuate 
potential biases. As catheter placement was not the main inter-
vention of interest in this study, there was no standard protocol 
for who would place the catheter and how the catheters were 
placed, whether ultrasound guidance was used during insertion, 
and certain catheter data that could have influenced dialysis 
dose delivered including lumen size and catheter length were 
not collected. This could potentially result in different rates of 
complication due to operator experience and also affected the 
outcome measures. However, in this study the complication rates 
were low and comparable among the groups. Another potential 
weakness in this study is the reliance on center reporting for 
complications, as there is a potential for underreporting of 
outcomes. However, given the data collected was part of the 
prospective trial for a different study intervention, the likelihood 
of this bias was low.
cOnclUsiOn
In conclusion, the femoral catheter site is a valuable location 
especially in the setting of emergency catheter placement or in 
patients with coagulopathy; hence, it is unlikely that we will aban-
don it as a catheter placement site. However, this study highlights 
7Ng et al. Acute Kidney Injury Vascular Access
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caution in the use of femoral site for dialysis catheter placement 
as it may result in a lower delivered dose of dialysis especially 
during IHD. As a result, judicious use of anticoagulation and/
or augmentation in the dose of dialysis prescribed may be neces-
sary in order to deliver comparable efficacy of dialysis with other 
catheter locations.
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